drugset / Trial / NCT02595554

Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer

NCT02595554 ↗

Phase 3 Unknown 220 enrolled Sun Yat-sen University
RandomizedSingle-groupOpen-labelTreatment

Summary

Neoadjuvant chemotherapy (NACT) and radical surgery (RS) may have a possible better outcome to concurrent chemoirradiation (CCRT) in stage IIB cervical cancer. We try to verify such a hypothesis in terms of survival and treatment related morbidity.

Timeline

Start
2015-11
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 70 mg/m2 —
Subject Paclitaxel Small molecule 150 mg/m2 —